Alistair Kent

• 
  www.lobbywatch.org/profile.asp?page=K - [Cached Version]
  Published on: 3/5/2009    Last Visited: 3/5/2009  

  Alistair Kent

• 
  www.sciencemediacentre.org/pages/press_releases/05-05-2 - [Cached Version]
  Published on: 5/23/2005    Last Visited: 10/5/2009  

  Alistair Kent, director of the Genetic Interest Group, said:

• 
  www.mult-sclerosis.org/news/Feb2004/ClonedHumanEmbryosY - [Cached Version]
  Published on: 9/7/2003    Last Visited: 4/14/2004  

  "It's an important breakthrough," says Alistair Kent, director of the Genetic Interest Group, an organization that supports those affected by genetic diseases.

• 
  www.agsd.org.uk/Workshops/Workshoparchive/tabid/1242/De - [Cached Version]
  Published on: 1/1/2003    Last Visited: 5/16/2009  

  Alistair Kent, Genetic Interest Group (GIG), Consequences of the Human Genome Project (HGP) on the Development of Treatments for Rare Disorders

• 
  www.lobbywatch.org/archive2.asp?arcid=3252 - [Cached Version]
  Published on: 4/1/2004    Last Visited: 8/22/2008  

  GIG director Alistair Kent had rallied protestors suffering hereditary diseases by claiming that they were about to be denied the change of a cure if MEPs did not vote for the Life Patent Directive.This time, the law passed.GlG's lobbying is widely credited as having been decisive in its approval.
  
  GlG's action attracted complaints from the very patient interest groups it was supposed to represent.The groups pointed out that GlG's policy had always been against gene patenting.Alistair Kent issued a letter restating the anti-patents-on-life views of the group, which were officially unchanged.So how did he come to behave in such a contrary fashion?

• 
  www.lobbywatch.org/archive2.asp?arcid=2785 - [Cached Version]
  Published on: 4/3/2004    Last Visited: 3/5/2009  

  GIG director Alistair Kent had rallied protestors suffering hereditary diseases by claiming that they were about to be denied the change of a cure if MEPs did not vote for the Life Patent Directive. This time, the law passed. GlG's lobbying is widely credited as having been decisive in its approval.
  
  GlG's action attracted complaints from the very patient interest groups it was supposed to represent. The groups pointed out that GlG's policy had always been against gene patenting. Alistair Kent issued a letter restating the anti-patents-on-life views of the group, which were officially unchanged. So how did he come to behave in such a contrary fashion?

• 
  www.e-unlimited.com/bff/P200126/programme.asp - [Cached Version]
  Published on: 4/28/2006    Last Visited: 12/6/2007  

  Speakers : Johan Vanhemelrijck (Secretary General) EuropaBio, Christian Siebert (Head of Unit) EC - DG Enterprise, Alistair Kent (Director) Genetic Interest Group

• 
  liberation-mag.org.uk/animaltesting2.html - [Cached Version]
  Published on: 10/7/2007    Last Visited: 10/7/2007  

  Alistair Kent, director of the Genetic Interest Group (GIG) said the statistics were good news for patients with serious diseases.He commented: "Each experiment brings the day closer when we no longer need to use animals, because then we will know enough to work safely with patients."

• 
  www.worldhealth.net/feeds/rss.asp?type=news&page=18 - [Cached Version]
  Published on: 5/1/2008    Last Visited: 5/16/2008  

  Alistair Kent, director of the Genetic Interest Group, advised that genetic information about future health risks should always be sought "in the context of a medical consultation with a clinician who can provide the appropriate information and counselling about the implications of having a test".
  
  Concerns have been raised in recent times about unscrupulous companies offering genetic tests.

• 
  www.phgu.org.uk/newsletter.php?newsletter_no=72 - [Cached Version]
  Published on: 6/1/2004    Last Visited: 11/13/2005  

  Alistair Kent, Director of the Genetics Interest Group, believes the research is necessary.

Page:  1 2 3 4 5